Download FREE Report Sample
Download Free sampleHepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
Mono Hepatitis B Vaccine Market contains market size and forecasts of Mono Hepatitis B Vaccine in global, including the following market information:
Global Mono Hepatitis B Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mono Hepatitis B Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Mono Hepatitis B Vaccine companies in 2021 (%)
The global Mono Hepatitis B Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Yeast Derived Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mono Hepatitis B Vaccine include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences and Serum Institute. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mono Hepatitis B Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mono Hepatitis B Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mono Hepatitis B Vaccine Market Segment Percentages, by Type, 2021 (%)
Yeast Derived
CHO Derived
Global Mono Hepatitis B Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mono Hepatitis B Vaccine Market Segment Percentages, by Application, 2021 (%)
Children
Adult
Global Mono Hepatitis B Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mono Hepatitis B Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mono Hepatitis B Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mono Hepatitis B Vaccine revenues share in global market, 2021 (%)
Key companies Mono Hepatitis B Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Mono Hepatitis B Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
